Mealey's (November 6, 2018, 11:57 AM EST) -- NEW ORLEANS — Efforts by the administrators of the Tulane Educational Fund and a Tulane University researcher to defeat counterclaims that they infringed two patents relating to endomorphin compounds were unsuccessful Nov. 5, when a Louisiana federal judge denied summary judgment (Administrators of the Tulane Educational Fund, et al. v. Cytogel Pharma LLC, No. 16-13987, E.D. La., 2018 U.S. Dist. LEXIS 187700)....